CSIMarket
 


Fibrogen Inc   (NASDAQ: FGEN)
Other Ticker:  
 
 

FGEN's EPS Net Growth by Quarter and Year

Fibrogen Inc 's EPS Net results by quarter and year

 



FGEN EPS Net (in $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 0.18 -0.55 -0.70
3rd Quarter September - -0.17 -0.65 -0.98
2nd Quarter June - -0.16 -0.90 -0.78
1st Quarter March 0.05 -0.33 -0.81 -0.68
FY   0.05 -0.48 -2.91 -3.14

FGENs Annual EPS Net
Fibrogen Inc 's EPS Net in the fiscal year 2024 $ -0.48
Fibrogen Inc 's EPS Net in the fiscal year 2023 $ -2.92
Fibrogen Inc 's EPS Net in the fiscal year 2022 $ -3.14
Fibrogen Inc 's EPS Net in the fiscal year 2021 $ -3.14
Fibrogen Inc 's EPS Net in the fiscal year 2019 $ -0.89




FGEN EPS Net first quarter 2025 Y/Y Growth Comment
Fibrogen Inc in the first quarter 2025 achieved EPS Net of $ 0.05 compare to EPS net loss recorded in same quarter a year ago.

Looking into first quarter 2025 results within Major Pharmaceutical Preparations industry 29 other companies have achieved higher EPS Net growth. While Fibrogen Inc ' s EPS Net no change of 0% ranks overall at the positon no. 1623 in the first quarter 2025.




FGEN EPS Net ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Fibrogen Inc 's first quarter 2025 EPS Net $ 0.05 FGEN's Income Statement
Fibrogen Inc 's first quarter 2024 EPS Net $ -0.33 Quarterly FGEN's Income Statement


FGEN EPS Net (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March -72.22 % - - -
FY (Year on Year)   - - - -




EPS Net first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #111
Overall #1623

EPS Net Y/Y Growth Statistics
High Average Low
-71.96 % -71.96 % -71.96 %
(Mar 31 2025)  
EPS Net first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #111
Overall #1623
EPS Net Y/Y Growth Statistics
High Average Low
-71.96 % -71.96 % -71.96 %
(Mar 31 2025)  

EPS Net by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Fibrogen Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
-71.96 % -71.96 % -71.96 %
(Mar 31 2025)  


FGEN's I. Quarter Q/Q EPS Net Comment
In the I. Quarter 2025 Fibrogen Inc disclosed fall in EPS Net from the fourth quarter by -72.22% to $ 0.05 , from $ 0.18 achived in the previous reporting period.

Within Major Pharmaceutical Preparations industry 29 other companies have achieved higher EPS Net quarter on quarter growth. While Fibrogen Inc 's EPS Net growth quarter on quarter, overall rank is 1623.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #111
Overall #1623
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #111
Overall #1623
EPS Net Q/Q Growth Statistics
High Average Low
-71.96 % -71.96 % -71.96 %
(Mar 31 2025)  


FGEN's I. Quarter Q/Q EPS Net Comment
In the I. Quarter 2025 Fibrogen Inc disclosed fall in EPS Net from the fourth quarter by -72.22% to $ 0.05 , from $ 0.18 achived in the previous reporting period.

Within Major Pharmaceutical Preparations industry 29 other companies have achieved higher EPS Net quarter on quarter growth. While Fibrogen Inc 's EPS Net growth quarter on quarter, overall rank is 1623.


Fibrogen Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2025)
12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
Cumulative EPS Net 12 Months Ending $ -0.10 $ -0.48 $ -1.21 $ -1.69 $ -2.43
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #


Cumulative EPS Net growth Comment


Fibrogen Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment


Fibrogen Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
FGEN's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for FGEN's Competitors
EPS Net Growth for Fibrogen Inc 's Suppliers
EPS Net Growth for FGEN's Customers

You may also want to know
FGEN's Annual Growth Rates FGEN's Profitability Ratios FGEN's Asset Turnover Ratio FGEN's Dividend Growth
FGEN's Roe FGEN's Valuation Ratios FGEN's Financial Strength Ratios FGEN's Dividend Payout Ratio
FGEN's Roa FGEN's Inventory Turnover Ratio FGEN's Growth Rates FGEN's Dividend Comparisons



Companies with similar EPS Net fall for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2025
Mettler Toledo International Inc-5.22%$ -5.218 
Pfizer Inc-5.45%$ -5.455 
Labcorp Holdings Inc -6.32%$ -6.320 
Abbvie Inc -6.49%$ -6.494 
National Research Corporation-7.41%$ -7.407 
Align Technology inc -8.63%$ -8.633 
Iqvia Holdings Inc -10.26%$ -10.256 
Utah Medical Products Inc-15.60%$ -15.596 
Ani Pharmaceuticals Inc-15.85%$ -15.854 
Mimedx Group Inc -16.67%$ -16.667 
Stryker Corp-17.56%$ -17.561 
Carlisle Companies Incorporated-19.40%$ -19.395 
Embecta Corp -20.00%$ -20.000 
West Pharmaceutical Services Inc -20.65%$ -20.645 
Davita Inc -24.53%$ -24.528 
Dexcom Inc -25.00%$ -25.000 
Envista Holdings Corporation-28.57%$ -28.571 
Dariohealth Corp -30.00%$ -30.000 
Insulet Corporation-31.51%$ -31.507 
Corcept Therapeutics Inc-32.00%$ -32.000 
Amphastar Pharmaceuticals Inc -37.04%$ -37.037 
Alkermes Plc -38.10%$ -38.095 
Biogen Inc -39.26%$ -39.259 
Vertex Pharmaceuticals Inc-40.86%$ -40.855 
Select Medical Holdings Corp-41.33%$ -41.333 
Becton Dickinson And Company-42.16%$ -42.162 
Solventum Corporation-43.07%$ -43.066 
Lantheus Holdings Inc -45.45%$ -45.455 
Pacira Biosciences inc -47.37%$ -47.368 
Organon and Co -57.69%$ -57.692 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com